Publications by authors named "Nadia Peragine"

Claim this Profile
N
NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of Gene Rearrangements.
Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani

Mediterr J Hematol Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sialylation regulates migration in chronic lymphocytic leukemia.
Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Ilaria Del Giudice, Roberta Soscia, Nadia Peragine

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.
Anna Guarini, Giulia Radice, Nadia Peragine, Chiara Buracchi, Maria Stefania De Propris

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels.
Maria Laura Bisegna, Iole Cordone, Nadia Peragine, Maria Laura Milani, Stefania Intoppa

Blood Cells Mol Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response.
Nadia Peragine, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Francesca Romana Mauro

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis.
Maria Laura Bisegna, Niccolò Noccioli, Irene Della Starza, Nadia Peragine, Alice Di Rocco

Mediterr J Hematol Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
Maria Stefania De Propris, Paolo Musiu, Stefania Intoppa, Maria Grazia Nardacci, Alessandra Pucciarini, Nadia Peragine

Br J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
Giovanni Fernando Torelli, Sabina Chiaretti, Nadia Peragine, Walter Barberi, Laura Santodonato

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with ibrutinib does not induce a clonal evolution in chronic lymphocytic leukemia.
Luciana Cafforio, Sara Raponi, Luca Vincenzo Cappelli, Caterina Ilari, Roberta Soscia, Nadia Peragine

Haematologica· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.
Maria Cristina Puzzolo, Giulia Radice, Nadia Peragine, Maria Stefania de Propris, Paola Mariglia

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Gian Matteo Rigolin, Ilaria Del Giudice, Antonella Bardi, Aurora Melandri, Rocio Edith García-Jacobo, Nadia Peragine

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
Maria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, Paola Mariglia, Maria Stefania De Propris

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab.
Nadia Peragine, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Paola Mariglia

Haematologica· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROR1 is an accurate and reliable marker of minimal residual disease in chronic lymphocytic leukaemia.
Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Paola Mariglia, Maria Grazia Nardacci, Nadia Peragine

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Michelina Santopietro, Maurizio Miano, Giovanna Palumbo, Kejian Zhang, Luisa Cardarelli, Nadia Peragine

Acta Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
Sara Raponi, Ilaria Del Giudice, Caterina Ilari, Luciana Cafforio, Monica Messina, Nadia Peragine

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies.
Valentina Gianfelici, Monica Messina, Francesca Paoloni, Nadia Peragine, Alessia Lauretti

Leuk Lymphoma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Anna Guarini, Nadia Peragine, Monica Messina, Marilisa Marinelli, Caterina Ilari

Br J Haematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Sabina Chiaretti, Monica Messina, Sara Grammatico, Alfonso Piciocchi, Anna L Fedullo, Nadia Peragine

Br J Haematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antileukemic potential of natural killer cells.
Giovanni F Torelli, Nadia Peragine, Paola Mariglia, Robin Foà

Immunotherapy· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Valentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, Filomena Di Giacomo, Monica Messina, Nadia Peragine

Haematologica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
Monica Messina, Sabina Chiaretti, Jiguang Wang, Anna Lucia Fedullo, Nadia Peragine

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD45 antigen negativity in T-lineage ALL correlates with PTPRC mutation and sensitivity to a selective JAK inhibitor.
Sara Raponi, Valentina Gianfelici, Sabina Chiaretti, Nadia Peragine, Fulvia Brugnoletti

Br J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
Giovanni F Torelli, Carmela Rozera, Laura Santodonato, Nadia Peragine, Giuseppina D'agostino

Blood Transfus· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Simona Tavolaro, Teresa Colombo, Sabina Chiaretti, Nadia Peragine, Valerio Fulci

Genes Chromosomes Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis